measles/rubella vaccine(Vaxxas)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemeasles/rubella vaccine(Vaxxas)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRubivirus InfectionsMorbillivirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandGambia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVaxxas Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVaxxas Pty Ltd
Inactive CompaniesN/A
Active IndicationsRubivirus InfectionsMorbillivirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A